Conformis, Inc. and SITES Medical announced they have entered into a non-exclusive development and supply agreement. The companies will work together to incorporate SITES Medical’s proprietary OsteoSync Ti Technology into future Conformis’ cementless total knee replacement products. OsteoSync™ Ti technology is a highly porous titanium bone ingrowth material designed to meet the needs of today’s health stakeholders from both clinical and economic standpoints. Its high friction coefficient promotes high initial implant stability and its open pore geometry, combined with micro and nano-texturing, facilitate superior bone ingrowth. Preclinical testing has demonstrated bone attachment strength nearly twice that of titanium plasma spray or beads, and between 2 and 5 times that of titanium 3D printed materials, a performance differential that can impact clinical outcomes, especially in cementless joint replacement patients. OsteoSync™ Ti technology has been used in over 50,000 procedures since it was first introduced for clinical use in 2014. The material is manufactured using highly innovative methods and offers substantial value for outpatient and inpatient facilities alike.